IE
SVNT

Israel Englander’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Israel Englander’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-308,226
Closed -$192K – 4126
2013
Q3 		$192K Hold
308,226
– – ﹤0.01% 3119
2013
Q2 		$173K Buy
+308,226
New +$215K ﹤0.01% 2793

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Israel Englander's SVNT Position: Q4 2013 in Review

Israel Englander sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 308,226 shares — an estimated $192K sold.

Israel Englander first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $192K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Israel Englander reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Israel Englander sold 308,226 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $192K.
  • Israel Englander first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Israel Englander's SAVIENT PHARMACEUTICALS INC position peaked at $192K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Millennium Management's 13F filing for Q4 2013, filed 14 Feb 2014.